Bo Unosson Hammarström
Director/Board Member at Helicure AB
Profile
Bo Unosson Hammarström is currently a Director at Helicure AB and UmanDiagnostics AB.
He was previously a Chairman at Merck SeQuant AB, an Investment Director at Uminova Invest AB, a Director at SpinChem AB, and a Director at EcoRub AB.
Bo Unosson Hammarström active positions
| Companies | Position | Start |
|---|---|---|
Helicure AB
 Helicure AB Pharmaceuticals: MajorHealth Technology Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden. | Director/Board Member | 2011-05-16 |
UmanDiagnostics AB
 UmanDiagnostics AB Medical SpecialtiesHealth Technology UmanDiagnostics AB provides medical diagnostics products and services. It offers products The NF-light to detect brain infections and it also has neurofilment light in cerebrospinal fluid which allows measurements in any conditions. The company was founded by Niklas Norgren and Torgny Stigbrand in 2006 and is headquartered in Umea, Sweden. | Director/Board Member | - |
Former positions of Bo Unosson Hammarström
| Companies | Position | End |
|---|---|---|
Uminova Invest AB
 Uminova Invest AB Investment ManagersFinance Uminova Invest AB is a regional venture capital firm formally established in 1992 and based in Umeå on the northern coast of Sweden. Since 2004 the shareholders of Uminova Invest include Uminova Holding AB, the holding company of Umeå University, as well as Industrifonden, Norrlandsfonden, Innovationsbron and Balticgruppen. The firm is part of the government-supported technology transfer and valorization system for academic research in Sweden, and has a strong regional focus. | Private Equity Investor | 2013-12-30 |
| ECORUB AB | Director/Board Member | - |
SpinChem AB
 SpinChem AB Industrial ConglomeratesProducer Manufacturing SpinChem AB engages in the development, manufacture, and sale of products for chemical synthesis. It offers SpinChem, an innovative concept for mass transfer enhancement in reactions involving solid phase reagents, encompassing several different ways of using the stirring element itself to establish a forced flow through a heterogeneous reactant or catalyst bed, which is located inside the stirrer body. The company was founded by Fredrik Almqvist and Kjell Robert Öberg in 2007 and is headquartered in Umea, Sweden. | Director/Board Member | - |
Merck SeQuant AB
 Merck SeQuant AB Medical SpecialtiesHealth Technology Merck SeQuant AB provides liquid chromatography technology and other related products. Its technology is used for analytical and preparative separation, purification of proteins, peptides, and polar compounds. The company offers services to the pharmaceutical industries and medical laboratories. Merck SeQuant was founded by Knut Irgum in 1987 and is located in Umea, Sweden | Chairman | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ECORUB AB | Producer Manufacturing |
| Private companies | 5 |
|---|---|
Merck SeQuant AB
Merck SeQuant AB Medical SpecialtiesHealth Technology Merck SeQuant AB provides liquid chromatography technology and other related products. Its technology is used for analytical and preparative separation, purification of proteins, peptides, and polar compounds. The company offers services to the pharmaceutical industries and medical laboratories. Merck SeQuant was founded by Knut Irgum in 1987 and is located in Umea, Sweden | Health Technology |
Uminova Invest AB
Uminova Invest AB Investment ManagersFinance Uminova Invest AB is a regional venture capital firm formally established in 1992 and based in Umeå on the northern coast of Sweden. Since 2004 the shareholders of Uminova Invest include Uminova Holding AB, the holding company of Umeå University, as well as Industrifonden, Norrlandsfonden, Innovationsbron and Balticgruppen. The firm is part of the government-supported technology transfer and valorization system for academic research in Sweden, and has a strong regional focus. | Finance |
Helicure AB
Helicure AB Pharmaceuticals: MajorHealth Technology Helicure AB develops and manufactures vaccines. It operates as a biotech company that focuses on developing vaccines for prevention of gastric cancer caused by Helicobacter pylori, through active immunisation in infected patients with persistent dyspepsia. The company was founded by Thomas Borén and Lennart Hammarström in 2005 and is headquartered in Umea, Sweden. | Health Technology |
SpinChem AB
SpinChem AB Industrial ConglomeratesProducer Manufacturing SpinChem AB engages in the development, manufacture, and sale of products for chemical synthesis. It offers SpinChem, an innovative concept for mass transfer enhancement in reactions involving solid phase reagents, encompassing several different ways of using the stirring element itself to establish a forced flow through a heterogeneous reactant or catalyst bed, which is located inside the stirrer body. The company was founded by Fredrik Almqvist and Kjell Robert Öberg in 2007 and is headquartered in Umea, Sweden. | Producer Manufacturing |
UmanDiagnostics AB
UmanDiagnostics AB Medical SpecialtiesHealth Technology UmanDiagnostics AB provides medical diagnostics products and services. It offers products The NF-light to detect brain infections and it also has neurofilment light in cerebrospinal fluid which allows measurements in any conditions. The company was founded by Niklas Norgren and Torgny Stigbrand in 2006 and is headquartered in Umea, Sweden. | Health Technology |
- Stock Market
- Insiders
- Bo Unosson Hammarström
